In a step toward disease-modifying therapy, Tufts researchers and collaborators have pioneered nanoparticles that target damaged cartilage and adapt to disease severity.
A group of School of Medicine professors and students took the pulse of their community to draft a roadmap for integrating the rapidly changing technology into the school's curriculum.